The process of metastasisation for breast cancer.

[1]  Umberto Veronesi,et al.  Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. , 2002, The New England journal of medicine.

[2]  B. E. F. Isher,et al.  Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. , 2002 .

[3]  Jong-Hyeon Jeong,et al.  Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. , 2002, The New England journal of medicine.

[4]  Kevin Hughes,et al.  Predicting the survival of patients with breast carcinoma using tumor size , 2002, Cancer.

[5]  I. Barillot,et al.  Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. , 2001, The New England journal of medicine.

[6]  Peter C Gøtzsche,et al.  Cochrane review on screening for breast cancer with mammography , 2001, The Lancet.

[7]  R. Gelber,et al.  Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  M. Baum,et al.  Axillary Dissection over the Years: Where To from Here? , 2001, World Journal of Surgery.

[9]  L. Tabár,et al.  Beyond randomized controlled trials , 2001, Cancer.

[10]  D. Hölzel,et al.  Qualitätssicherung in der Onkologie am Beispiel des Mammakarzinoms der Feldstudie München , 2001, Der Onkologe.

[11]  J. Peterse,et al.  Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  G. Viale,et al.  Sentinel lymph node biopsy as an indicator for axillary dissection in early breast cancer. , 2001, European journal of cancer.

[13]  Michael Schmidt,et al.  Modell zur primären und sekundären Metastasierung beim Mammakarzinom und dessen klinische Bedeutung , 2001, Strahlentherapie und Onkologie.

[14]  J. Vermorken.  Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials , 2000, The Lancet.

[15]  Mike Clarke,et al.  Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials , 2000 .

[16]  M. J. van de Vijver,et al.  Histological determinants for different types of local recurrence after breast-conserving therapy of invasive breast cancer. Dutch Study Group on local Recurrence after Breast Conservation (BORST) , 1999, European journal of cancer.

[17]  L. Sengeløv,et al.  Survival and pattern of failure following locoregional recurrence of breast cancer. , 1999, Clinical oncology (Royal College of Radiologists (Great Britain)).

[18]  B. Rasmussen,et al.  Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial , 1999, The Lancet.

[19]  P. Littlejohns,et al.  Influence of delay on survival in patients with breast cancer: a systematic review , 1999, The Lancet.

[20]  B. Haward,et al.  Effect on survival of delays in referral of patients with breast-cancer symptoms: a retrospective analysis , 1999, The Lancet.

[21]  D J Ferguson,et al.  Dormancy of mammary carcinoma after mastectomy. , 1999, Journal of the National Cancer Institute.

[22]  E. Touboul,et al.  Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer. , 1999, International journal of radiation oncology, biology, physics.

[23]  A. Fortin,et al.  Local failure is responsible for the decrease in survival for patients with breast cancer treated with conservative surgery and postoperative radiotherapy. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  M Tubiana,et al.  The link between local recurrence and distant metastases in human breast cancer. , 1999, International journal of radiation oncology, biology, physics.

[25]  R. Gelman,et al.  Editorial comment on "the link between local recurrence and distant metastasis in human breast cancer" by Serge Koscielny and Maurice Tubiana. , 1999, International journal of radiation oncology, biology, physics.

[26]  B. Fisher,et al.  Long-term follow-up of axillary node-positive breast cancer patients receiving adjuvant tamoxifen alone: patterns of recurrence. , 1998, International journal of radiation oncology, biology, physics.

[27]  Z. Agur,et al.  The growth law of primary breast cancer as inferred from mammography screening trials data. , 1998, British Journal of Cancer.

[28]  V. Bardou,et al.  Local and distant recurrence after conservative management of "very low-risk" breast cancer are dependent events: a 10-year follow-up. , 1998, International journal of radiation oncology, biology, physics.

[29]  J. Kurtz.  Tamoxifen and breast conservation , 1998 .

[30]  H. Johansson,et al.  A randomized trial of long term adjuvant tamoxifen plus postoperative radiation therapy versus radiation therapy alone for patients with early stage breast carcinoma treated with breast‐conserving surgery , 1998, Cancer.

[31]  Mike Clarke,et al.  Tamoxifen for early breast cancer: an overview of the randomised trials , 1998, The Lancet.

[32]  J. Witte,et al.  Monoclonal antibody therapy for resected Dukes' C colorectal cancer: seven-year outcome of a multicenter randomized trial. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  Evans Ra.  Radiotherapy and chemotherapy in high-risk breast cancer. , 1998 .

[34]  P. Homel,et al.  Radiotherapy and chemotherapy in high-risk breast cancer. , 1998, The New England journal of medicine.

[35]  I. Kunkler.  Benefits of post-mastectomy radiotherapy , 1998, The Lancet.

[36]  K. Mokbel,et al.  Benefits of post-mastectomy radiotherapy , 1998, The Lancet.

[37]  S. Braun,et al.  Re: Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status. , 1996, Journal of the National Cancer Institute.

[38]  R. Gelber,et al.  Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. , 1995, Journal of the National Cancer Institute.

[39]  D. M. Brown,et al.  The role of regional nodal irradiation in the management of patients with early-stage breast cancer treated with breast-conserving therapy. , 1997, International journal of radiation oncology, biology, physics.

[40]  J. Yarnold.  Benefits of post-mastectomy radiotherapy , 1997, The Lancet.

[41]  R. Demicheli,et al.  Proposal for a new model of breast cancer metastatic development. , 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

[42]  K. Zedeler,et al.  Postoperative Radiotherapy in High-Risk Premenopausal Women with Breast Cancer Who Receive Adjuvant Chemotherapy , 1997 .

[43]  S. Hellman.  Stopping metastases at their source. , 1997, The New England journal of medicine.

[44]  N. Le,et al.  Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. , 1997, The New England journal of medicine.

[45]  I. Jatoi.  Breast cancer: a systemic or local disease? , 1997, American journal of clinical oncology.

[46]  Umberto Veronesi,et al.  Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes , 1997, The Lancet.

[47]  J. Willner,et al.  Locoregional recurrence of breast cancer following mastectomy: always a fatal event? Results of univariate and multivariate analysis. , 1997, International journal of radiation oncology, biology, physics.

[48]  K. Pantel,et al.  Disseminierte Tumorzellen: Diagnostik, prognostische Relevanz, Phänotypisierung und therapeutische Strategien , 1997, Der Chirurg.

[49]  B. Salvadori.  Local recurrences after breast-conserving treatment: an open problem. , 1998, Seminars in surgical oncology.

[50]  N. Perry,et al.  European Guidelines for Quality Assurance in Mammography Screening , 1996 .

[51]  T. Whelan,et al.  Randomized Clinical Trial of Breast Irradiation Following Lumpectomy and Axillary Dissection for Node-Negative Breast Cancer: an Update , 1996 .

[52]  S. E. Reid,et al.  Endocrine and paracrine hormones in the promotion, progression and recurrence of breast cancer , 1996, The British journal of surgery.

[53]  L. Pierce,et al.  Defining the role of post-mastectomy radiotherapy: the new evidence. , 1996, Oncology.

[54]  A. Purushotham,et al.  Local recurrence after breast‐conserving surgery for breast cancer , 1996, The British journal of surgery.

[55]  R. Arriagada,et al.  Adequate locoregional treatment for early breast cancer may prevent secondary dissemination. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[56]  A. Threlfall,et al.  Is the three year breast screening interval too long? Occurrence of interval cancers in NHS breast screening programme's north western region , 1995, BMJ.

[57]  E Marubini,et al.  Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events. , 1995, Journal of the National Cancer Institute.

[58]  A. Hart,et al.  Prognostic factors for survival after breast conserving therapy for stage I and II breast cancer. The role of local recurrence. , 1995, European journal of cancer.

[59]  S. Levitt.  The importance of locoregional control in the treatment of breast cancer and its impact on survival , 1994, Cancer.

[60]  S J Schnitt,et al.  The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast‐conserving surgery and radiation therapy , 1994, Cancer.

[61]  S. Ciatto,et al.  Intensive Diagnostic Follow-up After Treatment of Primary Breast Cancer: A Randomized Trial , 1994 .

[62]  M Baum,et al.  Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[63]  Roland Holland,et al.  Age‐dependent growth rate of primary breast cancer , 1993, Cancer.

[64]  S. Hilsenbeck,et al.  Survival after first recurrence of breast cancer. The miami experience , 1992, Cancer.

[65]  C. Kiricuta,et al.  A mathematical model of axillary lymph node involvement based on 1446 complete axillary dissections in patients with breast carcinoma , 1992, Cancer.

[66]  Mike Clarke,et al.  Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 women , 1992 .

[67]  Anthony Howell,et al.  Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group. , 1992 .

[68]  C. Perez,et al.  Survival following locoregional recurrence of breast cancer: univariate and multivariate analysis. , 1992, International journal of radiation oncology, biology, physics.

[69]  I. Ellis,et al.  Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. , 2002, Histopathology.

[70]  C. Redmond,et al.  Significance of ipsilateral breast tumour recurrence after lumpectomy , 1991, The Lancet.

[71]  D. Fischer,et al.  Prognosis following local recurrence in the conservatively treated breast cancer patient. , 1991, International journal of radiation oncology, biology, physics.

[72]  M. Leivonen,et al.  Prognostic factors associated with survival after breast cancer recurrence. , 1991, Acta oncologica.

[73]  O. Kallioniemi,et al.  Prognostic factors in recurrent breast cancer: relationships to site of recurrence, disease-free interval, female sex steroid receptors, ploidy and histological malignancy grading. , 1990, British Journal of Cancer.

[74]  D. Schultz,et al.  Breast recurrence following conservative surgery and radiation: patterns of failure, prognosis, and pathologic findings from mastectomy specimens with implications for treatment. , 1990, International journal of radiation oncology, biology, physics.

[75]  F. Ames,et al.  Predicting the rate and extent of locoregional failure after breast conservation therapy for early breast cancer , 1989, Cancer.

[76]  J. Jacquemier,et al.  Local recurrence after breast‐conserving surgery and radiotherapy. Frequency, time course, and prognosis , 1989, Cancer.

[77]  J. Kurtz,et al.  Local recurrence after breast-conserving surgery and radiotherapy. , 1989, Helvetica chirurgica acta.

[78]  L. Skoog,et al.  Radiotherapy, chemotherapy, and tamoxifen as adjuncts to surgery in early breast cancer: a summary of three randomized trials. , 1989, International journal of radiation oncology, biology, physics.

[79]  C. Redmond,et al.  A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. , 1989, The New England journal of medicine.

[80]  S. Schnitt,et al.  Prognosis following local or regional recurrence after conservative surgery and radiotherapy for early stage breast carcinoma. , 1989, International journal of radiation oncology, biology, physics.

[81]  J. Peterse,et al.  The impact of tumor size and histology on local control after breast-conserving therapy. , 1988, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[82]  J. Harris,et al.  The appropriate breast cancer paradigm. , 1987, Cancer research.

[83]  S. Rosenberg,et al.  Complete axillary lymph node dissection for stage I-II carcinoma of the breast. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[84]  T. Hakulinen,et al.  Cancer survival corrected for heterogeneity in patient withdrawal. , 1982, Biometrics.

[85]  S. Shapiro,et al.  Lead time in breast cancer detection and implications for periodicity of screening. , 1974, American journal of epidemiology.

[86]  B. Fisher.  The surgical dilemma in the primary therapy of invasive breast cancer: a critical appraisal. , 1970, Current problems in surgery.

[87]  W. Halsted,et al.  I. The Results of Operations for the Cure of Cancer of the Breast Performed at the Johns Hopkins Hospital from June, 1889, to January, 1894. , 1894, Annals of surgery.